British Pharmacopoeia 1980 I-II [antikvár]

Preface The British Pharmacopoeia 1980 is published by Her Majesty's Statioriery Office for the Health Ministers on the recommendation of the Medicines Commission in accordance with section 99(6) of the Medicines Act 1968. This is the first edition of the Pharmacopoeia that has been prepared wholly under the provisions of the Medicines Act, a fact that is reflected in its greatly enlarged scope. Complete, edited texts of the European Pharmacopoeia requirements for many materials are included in fulfilment of the terms of the Convention on the Elaboration of a European Pharmacopoeia (Treaty Series No. 32: 1974). In addition, monographs for many materials that were formerly described in the British Pharmaceutical Codex have been included in accordance with an agreement reached between the Medicines Commission and the Pharmaceutical Society of Great Britain whereby after 1978 official standards for medicinal products will be provided only in the British Pharmacopoeia. The Medicines Commission believes that the role of the Pharmacopoeia in providing publicly available standards that apply to a product at any time during its shelf-life is of considerable value in safeguarding purchasers and users of medicinal products. The provisions of section 65 of the Medicines Act 1968 relating to the compliance of products with standards specified in monographs of the Pharmacopoeia may be used to supplement those of section 64 which prohibit the sale or the supply on prescription, to the prejudice of the purchaser, of any medicinal product which is not of the nature or quality demanded. The relevance of the publicly available specifications of the British Pharmacopoeia in this connection is clear. The preparation of this greatly enlarged version of the British Pharmacopoeia has made very heavy demands on the members of the British Pharmacopoeia Commission, its committees and its staff. The Medicines Commission wishes to record appreciation for the services of all who have contributed to this important work. In addition it acknowledges the ready co-operation of the majority of the industrial organisations that have been consulted for information and advice. This willing support has enabled the preparation and publication of the British Pharmacopoeia 1980 to be brought to a successful conclusion. Finally the Medicines Commission record their appreciation of the work carried out by members of the British Pharmacopoeia Commission who have recently retired. In particular they acknowledge the outstanding contributions made by Sir Frank Hartley and Dr D. C. Garratt, both of whom have served the British Pharmacopoeia Commission in many capacities for more than thirty years, Sir Frank Hartley having been Chairman since 1970. We benefit greatly from their unstinted efforts and wise counsel.